Aclaris Therapeutics, Inc.
ACRS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$132 | -$88 | -$87 | -$91 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | -$0 | $0 | $1 |
| Stock-Based Comp. | $11 | $21 | $15 | $14 |
| Change in WC | $11 | $9 | -$1 | -$1 |
| Other Non-Cash | $89 | -$20 | $5 | $24 |
| Operating Cash Flow | -$20 | -$78 | -$68 | -$52 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | -$13 | $167 |
| Inv. Purchases | -$120 | -$136 | -$165 | -$235 |
| Inv. Sales/Matur. | $86 | $183 | $178 | $68 |
| Other Inv. Act. | -$36 | $0 | $13 | -$167 |
| Investing Cash Flow | -$70 | $46 | $13 | -$168 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$11 |
| Stock Issued | $75 | $27 | $73 | $238 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | $0 | -$2 |
| Financing Cash Flow | $75 | $27 | $73 | $225 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$15 | -$5 | $18 | $5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $40 | $45 | $27 | $22 |
| End Cash | $25 | $40 | $45 | $27 |
| Free Cash Flow | -$20 | -$80 | -$68 | -$52 |